MedTrace Logo

Study to Identify Adequate Biomarker to Detect Vitamin B12 Deficiency in Type 2 Diabetic Patients Treated With Metformin

NCT02111967 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2015-08-13

No results posted yet for this study

Summary

In this study we compare the vitamin B12 status by measuring serum vitamin B12 and holotranscobalamin in type 2 diabetic patients with and without metformin treatment. Afterwars we investigate which biomarker could be adequate to reflect B12 status in metformin-treated patients.

With the help of a questionnaire we assess clinical, nutritional and demographic factors which are associated with vitamin B12 deficiency.

Conditions

  • Diabetes Mellitus Type 2

Interventions

OTHER

Questionnaire administration

OTHER

Laboratory biomarker analysis

Sponsors & Collaborators

  • University of Basel

    collaborator OTHER

  • Solothurner Spitäler AG

    collaborator UNKNOWN

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Kurt E Hersberger, Prof. · Pharmaceutical Care Research Group

  • Philipp N Walter, Dr. · Pharmaceutical Care Research Group

  • Gottfried Rudofsky, Prof. Dr. · Kantonsspital Olten

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02111967 on ClinicalTrials.gov